August 2015

New Product - ProQuad

ProQuad (measles, mumps, rubella and varicella) is a combined attenuated live virus vaccine. ProQuad is indicated for vaccination against measles, mumps, rubella, and varicella in individuals 12 months through 12 years of age. ProQuad is contraindicated in gelatin hypersensitivity; history of anaphylactoid reaction to neomycin; active febrile illness with fever > 38.5°C; active untreated TB; family history of congenital or hereditary immunodeficiency unless immune competence demonstrated; primary/ acquired immunodeficiency states including HIV, hypogammaglobulinaemia, dysgammaglobulinaemia, cellular immune deficiency; blood dyscrasia; malignancy affecting bone marrow, lymphatic system e.g. leukaemia, lymphoma; concomitant immunosuppressants (excluding topical/ low dose corticosteroids, corticosteroid replacement therapy); and pregnancy. ProQuad is available as a single use powder for injection vial in packs of 1’s and 10’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au